Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018

BACKGROUND: Medications to treat opioid use disorder (OUD) including buprenorphine products are evidence-based and cost-effective tools for combating the opioid crisis. However, limited availability to buprenorphine is pervasive in the United States (US) and may serve to exacerbate the deadly epidem...

Descripción completa

Detalles Bibliográficos
Autores principales: Conway, Kevin P., Khoury, Dalia, Hilscher, Rainer, Aldridge, Arnie P., Parker, Stephanie J., Zarkin, Gary A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802270/
https://www.ncbi.nlm.nih.gov/pubmed/35101112
http://dx.doi.org/10.1186/s13722-021-00282-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802270/
https://www.ncbi.nlm.nih.gov/pubmed/35101112
http://dx.doi.org/10.1186/s13722-021-00282-2

Ejemplares similares